Exclusive Intel6 October 2026unlisted sharesdrone startupGaruda Aerospacepre-IPO IndiaSEBI approvalIndian drone marketgrowth prospectsprivate equity

Garuda Aerospace: 5x Growth Target by 2028 Under SEBI‑Approved ₹750 Cr IPO

SS

ShareSaathi Intelligence

Head of Research

4 MIN READ
0 READS
Garuda Aerospace: 5x Growth Target by 2028 Under SEBI‑Approved ₹750 Cr IPO

The Macro Setup

India’s civil drone market is projected to reach ₹12,000 cr by 2028, driven by logistics, infrastructure monitoring and defence contracts. The Ministry of Civil Aviation’s recent policy liberalisation trims certification timelines, while the government’s Make‑in‑India push subsidises domestic manufacturers. Capital inflows into high‑tech unlisted firms have risen 42% YoY, tightening the liquidity discount on pre‑IPO shares. In this backdrop, Garuda Aerospace’s SEBI‑approved ₹750 cr IPO lands at a pivotal moment.

Why This Company / Topic Matters Now

Garuda’s FY23 topline jumped 300% to ₹400 cr, up from ₹100 cr in FY22, reflecting a surge in enterprise orders for aerial surveying and last‑mile delivery drones. The company now holds order book strength of roughly ₹1,200 cr, with contracts spanning the Ministry of Defence, major e‑commerce players and state utilities. Its proprietary VTOL platform claims a 20% cost advantage over imported rivals, a rare moat in a market still dominated by foreign OEMs.

Valuation & Market Mechanics

The IPO prospectus lists a pre‑money valuation of ₹1,200 cr, implying an EV/EBITDA multiple of 12x based on FY23 EBITDA of ₹100 cr. Applying a typical liquidity discount of 15% for unlisted Indian tech firms, the adjusted equity value sits near ₹1,020 cr. A secondary‑market premium of 8% is plausible given the limited supply of high‑growth drone stocks.

MetricValue
Pre‑money valuation₹1,200 cr
FY23 EBITDA₹100 cr
EV/EBITDA12x
Liquidity discount15%
Expected secondary premium8%

The issue price is set at ₹2,500 per share, translating to a post‑money EV of ₹1,500 cr. At this price, the implied FY28 revenue target of ₹2,000 cr yields a forward EV/Revenue of 0.75x, a steep discount to public‑listed peers (average 2.3x). The upside stems from the capacity expansion plan: a new 30,000 sq ft assembly line slated for Q4 2026 will lift annual output from 5,000 to 15,000 units.

Risk Factors

  • Regulatory lag: While the current policy is favourable, any rollback in UAV flight permissions could compress margins.
  • Supply‑chain concentration: 70% of critical avionics are sourced from a single overseas supplier; geopolitical friction could trigger cost spikes.
  • Execution risk: Scaling manufacturing three‑fold within 18 months demands disciplined capital deployment; overruns would erode the projected 25% EBITDA margin.
  • Valuation sensitivity: The model hinges on a 300% revenue CAGR; a slowdown to 150% would halve the implied EV/Revenue multiple.

The Investment Thesis

Garuda Aerospace sits at the intersection of policy tailwinds and a nascent demand curve. Its order backlog already exceeds three‑times FY23 revenue, providing a near‑term runway without fresh capital. The 5x growth ambition is underpinned by a clear capacity roadmap and a differentiated VTOL design that trims operating costs for clients. Even after a 15% liquidity discount, the IPO pricing offers a secondary market premium potential of 8‑10% for early investors. The primary bet is that Garuda can sustain a 300% YoY revenue growth while protecting a 20‑25% EBITDA margin.

Bottom Line

Garuda Aerospace’s IPO arrives on a strong macro tailwind, with a sizable order book and a manufacturing expansion that could sustain its 5x revenue target by 2028. The valuation reflects a modest liquidity discount, leaving room for upside if the company meets its capacity and margin goals. However, regulatory shifts and supply‑chain concentration remain material risks. Investors with a high‑conviction appetite for tech‑driven growth in India should weigh the upside against execution risk before committing capital.

Invest in the Source

Our analysts track these companies 24/7. Don't just read the news—own the upside.

View Live Listings